Public signalCompany raiseAuto-indexed · Unverified
iBio, Inc. raised $11.1M
iBio, Inc.· SAN DIEGO, US· Biotechnology· Filed May 7, 2025
iBio, Inc. reported raising capital. Based in SAN DIEGO, CALIFORNIA, US. First sale reported 2025-04-29. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$11.1M
Confidence90%
Raised
$11.1M
Investors
5
Jurisdiction
DELAWARE
On the record
- Location
- SAN DIEGO, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $11.1M
- Target amount
- $11.1M
- Filing date
- May 7, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 5
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $11.1M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Alexandra Kroptova
Director
San Diego, US
Antonio Parada
Director
San Diego, US
David Arkowitz
Director
San Diego, US
Evert Shimmelpennink
Director
San Diego, US
Felipe Duran
Executive Officer
San Diego, US
Gary Sender
Director
San Diego, US
Marc Banjak
Executive Officer
San Diego, US
Martin A. Brenner
Director
San Diego, US
William Clark
Director
San Diego, US
Sources & provenance
“Operating company sold 11,084,569 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated May 7, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with iBio, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record